Generate a tailored SOP for Dr. Anouschka Akerman. Improve your application with a focused, well-structured draft.
Anouschka Akerman completed her Bachelor of Science with Honours in 2014 and her PhD in cancer therapeutics with a focus on stromal cell metabolism in 2019, both at the University of New South Wales (UNSW) in the Faculty of Medicine & Health, specifically at the Kirby Institute. Her doctoral research concentrated on understanding therapeutically targeting tumor-stromal interactions in pancreatic cancer. Following her PhD, she worked at the Medicine Research Infrastructure Operational Services team within the Upper Campus Biomedical Precinct from 2020 to 2021. In 2021, she joined the Viral Pathogenesis Vector Laboratory as part of the Immunovirology Pathogenesis Program at the Kirby Institute, where she manages projects related to SARS-CoV-2 and Mpox. Anouschka's research interests include targeting metabolic changes in pancreatic tumor cells and tumor-associated stromal cells, with an aim to identify pharmacological inhibitors and gene therapies for treatment. She has received multiple scholarships and awards, including the UNSW Dean’s Award for Outstanding PhD Theses (2019) and the Australian Postgraduate Award Scholarship (2015-2018).
Kirby Institute • Sydney, Australia
Managing projects on SARS-CoV-2 and Mpox in the Viral Pathogenesis Vector Laboratory.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.